News & Analysis as of

Combating Unfair Competition: The Convergence of China’s Antitrust and Anti-Graft Enforcement Activities

Recent investigations and high profile convictions highlight the ongoing crackdown by China’s authorities against anti-competitive conduct. In their efforts to combat unfair competition, Chinese authorities have used both...more

Life Sciences Spotlight - Issue 4, 2014

Since our last edition, there has been a number of developments in the Life Sciences sector across the Asia Pacific region and we are pleased to be able to update you on these recent trends. It is evident that the...more

Business Litigation Report -- June 2014

In This Issue: - Main Article: ..Tronox Inc. v. Anadarko Petroleum Corp. (In re Tronox Inc.) – Bankruptcy Court Takes Unusual Steps to Declare Corporate Restructuring a Fraudulent Transfer - Noted With...more

China’s Anti-Graft Campaign: Implications for Multi-Nationals Operating in China

Chinese anti-corruption efforts historically targeted recipients of bribes, particularly government officials. In the past year, however, Chinese authorities have initiated a very public crackdown on bribe payers in the life...more

China’s Life Sciences Regulatory Crackdown: September 10 Update

The regulatory enforcement environment in China remains tense, as both the Chinese government and media bring new actions and allegations against life sciences manufacturers in both the pharmaceutical and device sectors. We...more

Life Sciences Spotlight | Issue 3, 2013

IN THIS ISSUE: - FEATURES: - A new wave of regulatory enforcement actions in China – Are we witnessing a prolonged enforcement cycle? - Update on recent decisions - Australia’s innovation patent – The...more

China Life Sciences Health Industry Client Briefing – May/June 2013 (July 12, 2013)

Pharmaceuticals, Medical Devices, Health Care & Life Sciences - .. Medical Devices Regulations and News - Provincial FDAs to Approve Certain Changes to Medical Device Registration Certificates – June 21,...more

Mofo Tech -- Spring/Summer 2013

In This Issue: - Here Come the Feds -- What President Obama’s second term means for the tech industry - Log In: ...Feds cast an eye on social media - Focus: ...3-D’s IP dimension -...more

China Life Sciences Health Industry Client Briefing – February 2013 (March 11, 2013)

In This Issue: New Drug GSP Issued: Supervision on Drug Distribution to be Enhanced (China Securities Journal 2013-02-20) – February 20, 2013; China to Encourage Innovative Drug Development (Xinhua News Agency...more

China Life Sciences Health Industry Client Briefing – January 2013 (February 21, 2013)

In This Issue: Li Keqiang Comments from the 12th Plenary Meeting of the Medical Reform Leading Group (USCBC 2012-01-06) – January 6, 2013; MOH Announces Roadmap for Medical Reform (USCBC 2012-01-10) – January 10, 2013;...more

China Life Sciences Health Industry Client Briefing - December 2012 (January 18, 2013)

Pharmaceuticals, Medical Devices, Health Care & Life Sciences - News & Regulations: ..Industry Calls for Reform of Lagging Drug Review System (Global Times 2012-12-02) – December 3, 2012...more

Skadden's 2013 Insights

We are pleased to provide a collection of commentaries on the critical legal issues facing our clients in 2013. There is hope that global economic and market conditions will continue to improve despite ongoing...more

China Life Sciences - January 2013

In This Issue: Investor Q&A; Key Regulatory Issues for Strategic Life Sciences Partnerships in China; Compulsory Patent Licensing in China; and New Developments on the “Patentable Subject Matter” Requirement of U.S....more

China Life Sciences and Health Industry Client Briefing – November 2012 (December 13, 2012)

In This Issue: Priorities, Practical Tips and Lessons Learned from Reed Smith’s China Device Regulatory Briefing on December 4, 2012; Programs of Designated Drug Production to be Initiated: Five to 10 Pilot Varieties...more

China Life Sciences and Health Industry Client Briefing – October 2012 (November 16, 2012)

In This Issue: - China Becoming Healthcare R&D Hub (China Daily 2012-10-09) – October 9, 2012 - Imported Drugs to Go on China's Electronic Monitoring Network (Xinhua News Agency 2012-10-08) – October 9, 2012...more

China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

In This Issue: • Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012 • Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14,...more

China Life Sciences and Health Industry Client Briefing – July 2012 (August 8, 2012)

In This Issue: - Counterfeit Drug Crackdown in China (Xinhua News Agency 2012-08-05) – August 5, 2012 - China Agencies Drafting Policies to Accelerate Development of Medical Devices, Supporting Fund to be...more

Life Sciences Health Industry China Briefing - June 2012 (July 20, 2012)

In This Issue: - China's Compulsory License Rule Has Drug Companies On Edge (Law360 2012-06 12) — June 14, 2012 - Beijing to Carry out Pilot Project of Separation of Dispensing from Prescription: Medical...more

Life Sciences Health Industry China Briefing – May 2012 (June 14, 2012)

In This Issue: News - Introduction of Administrative Measures on Clinical Application of Antimicrobial Drugs (Ministry of Health 2012-05-08) – May 9, 2012 The Ministry of Health recently issued the...more

China Life Sciences Newsletter -- April 2012

In This Issue: *Investor Q&A *Trends and Best Practices in R&D Strategic Partnerships in China *USPTO Proposed Rules on Preissuance Submissions Excerpt from Investor Q&A Interview by Chuck Comey,...more

CHINA BRIEFING January 2012 (February 13, 2012) - Pharmaceuticals, Devices, Health Care & Life Sciences

In This Issue: Regulations & News Excerpt from Regulations • Notice from the Ministry of Health concerning the Outline of China’s Nursing Development Plan from 2011 to 2015 – January 9, 2012 On...more

China Life Sciences - December 2011

In this issue: Investor Q&A; Implications of the Leahy-Smith America Invents Act for Chinese Life Science Companies; Frequent Issues Arising in Acquisitions of China Life Sciences Targets; and Key Regulatory...more

China Life Sciences: Moving Towards Full Impact

I recently spent some time in the “Golden Triangle,” which on its Northern edge is delineated by the area between Nanjing and Shanghai. What is initially striking is the absolutely mammoth investment in infrastructure that...more

23 Results
|
View per page
Page: of 1